ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $66,000 | +20.0% | 35,196 | +0.3% | 0.00% | – |
Q4 2020 | $55,000 | +48.6% | 35,104 | -2.8% | 0.00% | – |
Q3 2020 | $37,000 | -65.1% | 36,111 | -1.0% | 0.00% | -100.0% |
Q2 2020 | $106,000 | +55.9% | 36,462 | +12.7% | 0.00% | – |
Q1 2020 | $68,000 | -1.4% | 32,339 | +54.2% | 0.00% | – |
Q4 2019 | $69,000 | +50.0% | 20,972 | +3.2% | 0.00% | – |
Q3 2019 | $46,000 | -53.1% | 20,325 | -0.7% | 0.00% | – |
Q2 2019 | $98,000 | -33.3% | 20,466 | +2.7% | 0.00% | -100.0% |
Q1 2019 | $147,000 | 0.0% | 19,933 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $147,000 | -44.5% | 20,578 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $265,000 | -17.4% | 20,736 | +3.2% | 0.00% | 0.0% |
Q2 2018 | $321,000 | +24.4% | 20,092 | +11.7% | 0.00% | 0.0% |
Q1 2018 | $258,000 | -14.0% | 17,986 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $300,000 | +8.3% | 18,954 | +16.7% | 0.00% | 0.0% |
Q3 2017 | $277,000 | +188.5% | 16,235 | +8.1% | 0.00% | – |
Q2 2017 | $96,000 | -99.4% | 15,021 | +148.2% | 0.00% | – |
Q1 2016 | $15,000,000 | -25.0% | 6,051 | 0.0% | 0.00% | – |
Q4 2015 | $20,000,000 | +79900.0% | 6,051 | -0.2% | 0.00% | – |
Q3 2015 | $25,000 | -99.9% | 6,062 | +0.1% | 0.00% | – |
Q2 2015 | $30,638,000 | – | 6,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,359,767 | $3,481,000 | 1.41% |
DAFNA Capital Management LLC | 181,818 | $465,000 | 0.40% |
Perceptive Advisors | 1,762,881 | $4,512,000 | 0.40% |
SPHERA FUNDS MANAGEMENT LTD. | 468,050 | $1,198,000 | 0.26% |
Soros Fund Management | 1,462,122 | $3,743,000 | 0.08% |
SABBY MANAGEMENT, LLC | 334,108 | $855,000 | 0.04% |
KLCM Advisors, Inc. | 28,612 | $73,000 | 0.02% |
CAMBRIDGE TRUST CO | 65,414 | $167,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 35,400 | $91,000 | 0.01% |
IFP Advisors, Inc | 10,000 | $74,000 | 0.01% |